pembrolizumab
merck
['keynote-412', 'pembro']
primary results from keynote-412 just in from #esmo22: although the difference in efs did not reach statistical significance, a favorable efs improvement trend was observed with pembro + crt vs placebo + crt in patients with la-hnscc with no new safety signals seen #noeticinsight 